| PERIOD ENDING | 25-Jan-09 | 27-Jan-08 | 28-Jan-07 | | Total Revenue | 3,424,859 | 4,097,860 | 3,068,771 | | Cost of Revenue | 2,250,590 | 2,228,580 | 1,768,322 | | | Gross Profit | 1,174,269 | 1,869,280 | 1,300,449 | | | Operating Expenses | | Research Development | 855,879 | 691,637 | 553,467 | | Selling General and Administrative | 362,222 | 341,297 | 293,530 | | Non Recurring | 26,868 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (70,700) | 836,346 | 453,452 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 28,152 | 65,049 | 41,049 | | Earnings Before Interest And Taxes | (42,548) | 901,395 | 494,501 | | Interest Expense | 406 | 54 | 21 | | Income Before Tax | (42,954) | 901,341 | 494,480 | | Income Tax Expense | (12,913) | 103,696 | 46,350 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (30,041) | 797,645 | 448,130 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| 704 | | Other Items |
-
|
-
|
-
| | | | Net Income | (30,041) | 797,645 | 448,834 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($30,041) | $797,645 | $448,834 |
|
0.16% Nasdaq 0.00%
Income Statement
